Scientists at the Allen Institute for Cell Science have developed an open-source stem cell line with fluorescent tags for cardiac cells.
Originally from Mumbai, Sukanya Charuchandra is a freelance science writer based out of wherever her travels take her. She holds master’s degrees in Science Journalism and Biotechnology. You can read her work at sukanyacharuchandra.com.
View Full Profile
Learn about our Editorial Policies.
The Allen Institute for Cell Science's cell collection has recently added five human induced pluripotent stem cell lines bringing the total number of cell lines openly available to researchers to 24.
Among the latest entrants is a cell line with a fluorescently tagged protein specific to heart muscle cells, called cardiomyocytes. The tagged protein, troponin I1, is produced only after the stem cells transform into cardiac cells.
Originally from Mumbai, Sukanya Charuchandra is a freelance science writer based out of wherever her travels take her. She holds master’s degrees in Science Journalism and Biotechnology. You can read her work at sukanyacharuchandra.com.
View Full Profile
Memory-enhancing neural networks may also drive involuntary musical loops in the brain.
View this Issue
In this webinar, learn how scientists use advanced human brain models to uncover treatment strategies for complex neurological conditions.
Modern DNA synthesis platforms empower researchers to explore the molecular world, from next-generation sequencing to cell and gene therapy development.
An improved chromatography membrane elution method helps scientists achieve higher yields of pure plasmid DNA.
By fine-tuning polishing conditions, scientists attain high titers of infectious lentiviral particles during purification.
This new product line is specifically engineered to meet the rigorous demands of immunology research, vaccine development, animal studies, cell and gene therapy, and therapeutic protein manufacturing.
New fluidics and clog detection systems further simplify operation and reduce instrument downtime
Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies
Study identifies new metrics to enhance scRNA-seq based virtual cell modelling
